ClinicalTrials.gov
ClinicalTrials.gov Menu

Bronchial Response to Mannitol and Inflammation in Steroid Naive Asthmatics.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00206973
Recruitment Status : Unknown
Verified September 2005 by Bispebjerg Hospital.
Recruitment status was:  Recruiting
First Posted : September 21, 2005
Last Update Posted : September 21, 2005
Sponsor:
Information provided by:
Bispebjerg Hospital

Brief Summary:
Study on the relationship between the response of the airways to a bronchial provocation test with mannitol and the degree of airway inflammation in asthma patients.

Condition or disease Intervention/treatment
Asthma Procedure: mannitol test

Detailed Description:
Study on the relationship between the response of the airways to a bronchial provocation test with mannitol and the degree of airway inflammation in asthma patients.

Study Type : Observational
Enrollment : 40 participants
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Official Title: Bronchial Response to Mannitol and Inflammation in Steroid Naive Asthmatics
Study Start Date : August 2005
Study Completion Date : September 2005

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Asthma
Drug Information available for: Mannitol
U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Steroid naive asthma.
  • Non-smoker

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00206973


Contacts
Contact: Celeste Porsbjerg, MD +45 35313069 porsbjerg@dadlnet.dk

Locations
Denmark
Respiratory Research Unit, Med. Clinic I, Bispebjerg Hospital, Bispebjerg Bakke 23 Recruiting
Copenhagen, NV, Denmark, 2400
Contact: Celeste Porsbjerg, MD    + 45 35313069    porsbjerg@dadlnet.dk   
Contact: Vibeke Backer, MD    35313069    backer@dadlnet.dk   
Principal Investigator: Celeste Porsbjerg, MD         
Sponsors and Collaborators
Bispebjerg Hospital
Investigators
Principal Investigator: Celeste porsbjerg, MD unaffilliated

ClinicalTrials.gov Identifier: NCT00206973     History of Changes
Other Study ID Numbers: 7654 - man 05
First Posted: September 21, 2005    Key Record Dates
Last Update Posted: September 21, 2005
Last Verified: September 2005

Additional relevant MeSH terms:
Inflammation
Pathologic Processes
Mannitol
Diuretics, Osmotic
Diuretics
Natriuretic Agents
Physiological Effects of Drugs